ISG15 and acute myeloid leukemia: Additionally, studies have demonstrated reduced expression of UBE2L6 in primary acute myeloid leukemia (AML) cells, where silencing UBE2L6 inhibits ATRA-induced ISG15 conjugation, thus impairing isgylation and hindering AML cell differentiation (43).